Skip to main content
HairCited

Alopecia areata: An appraisal of new treatment approaches and overview of current therapies.

Lauren C Strazzulla, Eddy Hsi Chun Wang, Lorena Avila, Kristen Lo Sicco, Nooshin Brinster et al.
Review Journal of the American Academy of Dermatology 2018 114 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D29241773'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Review
Population
Patients with alopecia areata
Intervention
Alopecia areata: An appraisal of new treatment approaches and overview of current therapies. None
Comparateur
None
Critère de jugement principal
Hair regrowth in alopecia areata
Direction de l'effet
Mixed
Risque de biais
Unclear

Abstract

Many therapies are available for the treatment of alopecia areata, including topical, systemic, and injectable modalities. However, these treatment methods produce variable clinical outcomes and there are no currently available treatments that induce and sustain remission. When making management decisions, clinicians must first stratify patients into pediatric versus adult populations. Disease severity should then be determined (limited vs extensive) before deciding the final course of therapy. The second article in this continuing medical education series describes the evidence supporting new treatment methods, among them Janus kinase inhibitors. We evaluate the evidence concerning the efficacy, side effects, and durability of these medications. An overview of conventional therapy is also provided with new insights gleaned from recent studies. Finally, future promising therapeutic options that have not yet been fully evaluated will also be presented.

En bref

The evidence supporting new treatment methods, among them Janus kinase inhibitors, are described and an overview of conventional therapy is provided with new insights gleaned from recent studies.

Used In Evidence Reviews

Similar Papers